Estrogen receptor neurobiology and its potential for translation into broad spectrum therapeutics for CNS disorders

Current Molecular Pharmacology

Volumn 2, Issue 3, 2009, Pages 215-236

  Hughes, Zoë A ^a   Liu, Feng ^a   Marquis, Karen ^a   Muniz, Luis ^a   Pangalos, Menelas N ^a   Ring, Robert H ^a   Whiteside, Garth T ^a   Brandon, Nicholas J ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; APOLIPOPROTEIN E; ATYPICAL ANTIPSYCHOTIC AGENT; DOPAMINE 2 RECEPTOR; ERB 131; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ALPHA AGONIST; ESTROGEN RECEPTOR BETA; ESTROGEN RECEPTOR BETA AGONIST; G PROTEIN COUPLED RECEPTOR 30; GLUTAMATE TRANSPORTER; HALOPERIDOL; HORMONE RECEPTOR STIMULATING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; PLACEBO; PRINABEREL; PROGESTERONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TAU PROTEIN; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANXIETY; ARTICLE; BIPOLAR DEPRESSION; BRAIN REGION; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; COGNITION; COMBINATION CHEMOTHERAPY; DENDRITIC SPINE; DEPRESSION; DISEASE PREDISPOSITION; DRUG EFFICACY; DRUG POTENTIATION; ELECTROCONVULSIVE THERAPY; GENE EXPRESSION; GENE LOCATION; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HORMONE SUBSTITUTION; HUMAN; LONG TERM DEPRESSION; LONG TERM POTENTIATION; LOW DRUG DOSE; MAJOR DEPRESSION; MENOPAUSE; MONOTHERAPY; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROBIOLOGY; NEUROPATHIC PAIN; NEUROPROTECTION; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NOCICEPTION; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RNA TRANSLATION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SYNAPSE; SYNAPTIC TRANSMISSION; SYNAPTOGENESIS; TREATMENT RESPONSE;

EID: 77952383972     PISSN: 18744672     EISSN: 18744702     Source Type: Journal    
DOI: 10.2174/1874467210902030215     Document Type: Article

References (283)

1. Couse, J. F.; Korach, K. S. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr. Rev. 1999, 20(3), 358-417.
2. Pettersson, K.; Gustafsson, J. A. Role of estrogen receptor beta in estrogen action. Annu. Rev. Physiol. 2001, 63, 165-192.
3. Piu, F.; Cheevers, C.; Hyldtoft, L.; Gardell, L. R.; Del Tredici, A. L.; Andersen, C. B.; Fairbairn, L. C.; Lund, B. W.; Gustafsson, M.; Schiffer, H. H.; Donello, J. E.; Olsson, R.; Gil, D. W.; Brann, M. R. Broad modulation of neuropathic pain states by a selective estrogen receptor beta agonist. Eur. J. Pharmacol. 2008, 590(1-3), 423-429.
4. Spooner, M. F.; Robichaud, P.; Carrier, J. C.; Marchand, S. Endogenous pain modulation during the formalin test in estrogen receptor beta knockout mice. Neuroscience 2007, 150(3), 675-680.
5. Jensen, E.; Jacobson, H. Basic guides to the mechanism of estrogen action. Recent Prog. Horm. Res. 1962, 18, 387-414.
6. McEwen, B. S.; Alves, S. E. Estrogen Actions in the Central Nervous System. Endocr. Rev. 1999, 20(3), 279-307.
7. Pfaff, D. W.; Vasudevan, N.; Kia, H. K.; Zhu, Y. S.; Chan, J.; Garey, J.; Morgan, M.; Ogawa, S. Estrogens, brain and behavior: studies in fundamental neurobiology and observations related to women's health. J. Steroid Biochem. Mol. Biol. 2000, 74(5), 365-373.
8. Prossnitz, E. R.; Arterburn, J. B.; Sklar, L. A. GPR30: A G protein-coupled receptor for estrogen. Mol. Cell. Endocrinol. 2007, 265-266, 138-142.
9. Evans, R. M. The steroid and thyroid hormone receptor superfamily. Science 1988, 240(4854), 889-895.
10. Greene, G. L.; Gilna, P.; Waterfield, M.; Baker, A.; Hort, Y.; Shine, J. Sequence and expression of human estrogen receptor complementary DNA. Science 1986, 231(4742), 1150-1154.
11. Flouriot, G.; Griffin, C.; Kenealy, M.; Sonntag-Buck, V.; Gannon, F. Differentially expressed messenger RNA isoforms of the human estrogen receptor-alpha gene are generated by alternative splicing and promoter usage. Mol. Endocrinol. 1998, 12(12), 1939-1954.
12. Herynk, M. H.; Fuqua, S. A. Estrogen receptor mutations in human disease. Endocr. Rev. 2004, 25(6), 869-898.
13. van Dijk, M. A.; Hart, A. A.; van't Veer, L. J. Differences in estrogen receptor alpha variant messenger RNAs between normal human breast tissue and primary breast carcinomas. Cancer Res. 2000, 60(3), 530-533.
14. Poola, I.; Speirs, V. Expression of alternatively spliced estrogen receptor alpha mRNAs is increased in breast cancer tissues. J. Steroid Biochem. Mol. Biol. 2001, 78(5), 459-469.
15. Perlman, W. R.; Matsumoto, M.; Beltaifa, S.; Hyde, T. M.; Saunders, R. C.; Webster, M. J.; Rubinow, D. R.; Kleinman, J. E.; Weickert, C. S. Expression of estrogen receptor alpha exon-deleted mRNA variants in the human and non-human primate frontal cortex. Neuroscience 2005, 134(1), 81-95.
16. Garcia Pedrero, J. M.; Zuazua, P.; Martinez-Campa, C.; Lazo, P. S.; Ramos, S. The naturally occurring variant of estrogen receptor (ER) ERDeltaE7 suppresses estrogen-dependent transcriptional activation by both wild-type ERalpha and ERbeta. Endocrinology 2003, 144(7), 2967-2976.
17. Koehorst, S. G.; Cox, J. J.; Donker, G. H.; Lopes da Silva, S.; Burbach, J. P.; Thijssen, J. H.; Blankenstein, M. A. Functional analysis of an alternatively spliced estrogen receptor lacking exon 4 isolated from MCF-7 breast cancer cells and meningioma tissue. Mol. Cell. Endocrinol. 1994, 101(1-2), 237-245.
18. Wilson, M. E.; Westberry, J. M.; Prewitt, A. K. Dynamic regulation of estrogen receptor-alpha gene expression in the brain: a role for promoter methylation? Front Neuroendocrinol. 2008, 29(3), 375-385.
19. Kuiper, G. G. J. M.; Enmark, E.; Pelto-Huikko, M.; Nilsson, S.; Gustafsson, J. -A. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA 1996, 93(12), 5925-5930.
20. Mosselman, S.; Polman, J.; Dijkema, R. ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett. 1996, 392(1), 49-53.
21. Moore, J. T.; McKee, D. D.; Slentz-Kesler, K.; Moore, L. B.; Jones, S. A.; Horne, E. L.; Su, J. -L.; Kliewer, S. A.; Lehmann, J. M.; Willson, T. M. Cloning and characterization of human estrogen receptor beta isoforms. Biochem. Biophys. Res. Commun. 1998, 247(1), 75-78.
22. Leung, Y. K.; Mak, P.; Hassan, S.; Ho, S. M. Estrogen receptor (ER)-beta isoforms: a key to understanding ER-beta signaling. Proc. Natl. Acad. Sci. USA 2006, 103(35), 13162-13167.
23. Ogawa, S.; Inoue, S.; Watanabe, T.; Orimo, A.; Hosoi, T.; Ouchi, Y.; Muramatsu, M. Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor ofestrogen action in human. Nucl. Acids Res. 1998, 26(15), 3505-3512.
24. Poola, I.; Abraham, J.; Baldwin, K.; Saunders, A.; Bhatnagar, R. Estrogen receptors beta4 and beta5 are full length functionally distinct ERbeta isoforms: cloning from human ovary and functional characterization. Endocrine 2005, 27(3), 227-238.
25. Weiser, M. J.; Foradori, C. D.; Handa, R. J. Estrogen receptor beta in the brain: From form to function. Brain Res. Rev. 2008, 57(2), 309-320.
26. Kuiper, G. G.; Gustafsson, J. A. The novel estrogen receptor-beta subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens. FEBS Lett. 1997, 410(1), 87-90.
27. Krege, J. H.; Hodgin, J. B.; Couse, J. F.; Enmark, E.; Warner, M.; Mahler, J. F.; Sar, M.; Korach, K. S.; Gustafsson, J. A.; Smithies, O. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc. Natl. Acad. Sci. USA 1998, 95(26), 15677-15682.
28. Rissman, E. F.; Wersinger, S. R.; Taylor, J. A.; Lubahn, D. B. Estrogen receptor function as revealed by knockout studies: neuroendocrine and behavioral aspects. Horm. Behav. 1997, 31(3), 232-243.
29. Meyers, M. J.; Sun, J.; Carlson, K. E.; Marriner, G. A.; Katzenellenbogen, B. S.; Katzenellenbogen, J. A. Estrogen Receptor-beta Potency-Selective Ligands: Structure-Activity Relationship Studies of Diarylpropionitriles and Their Acetylene and Polar Analogues. J. Med. Chem. 2001, 44(24), 4230-4251.
30. Stauffer, S. R.; Coletta, C. J.; Tedesco, R.; Nishiguchi, G.; Carlson, K.; Sun, J.; Katzenellenbogen, B. S.; Katzenellenbogen, J. A. Pyra-zole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists. J. Med. Chem. 2000, 43(26), 4934-4947.
31. Barkhem, T.; Carlsson, B.; Nilsson, Y.; Enmark, E.; Gustafsson, J.; Nilsson, S. Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. Mol. Pharmacol. 1998, 54(1), 105-112.
32. Harris, H. A. Estrogen receptor beta: recent lessons from in vivo studies. Mol. Endocrinol. 2007, 21(1), 1-13.
33. Mufson, E. J.; Cai, W. J.; Jaffar, S.; Chen, E.; Stebbins, G.; Sendera, T.; Kordower, J. H. Estrogen receptor immunoreactivity within subregions of the rat forebrain: neuronal distribution and association with perikarya containing choline acetyltransferase. Brain Res. 1999, 849(1-2), 253-274.
34. Osterlund, M. K.; Grandien, K.; Keller, E.; Hurd, Y. L. The human brain has distinct regional expression patterns of estrogen receptor alpha mRNA isoforms derived from alternative promoters. J. Neurochem. 2000, 75(4), 1390-1397.
35. Osterlund, M. K.; Gustafsson, J. A.; Keller, E.; Hurd, Y. L. Estrogen receptor beta (ERbeta) messenger ribonucleic acid (mRNA) expression within the human forebrain: distinct distribution pattern to ERalpha mRNA. J. Clin. Endocrinol. Metab. 2000, 85(10), 3840-3846.
36. Osterlund, M. K.; Keller, E.; Hurd, Y. L. The human forebrain has discrete estrogen receptor alpha messenger RNA expression: high levels in the amygdaloid complex. Neuroscience 2000, 95(2), 333-342.
37. Gonzalez, M.; Cabrera-Socorro, A.; Perez-Garcia, C. G.; Fraser, J. D.; Lopez, F. J.; Alonso, R.; Meyer, G. Distribution patterns of estrogen receptor alpha and beta in the human cortex and hippocampus during development and adulthood. J. Comp. Neurol. 2007, 503(6), 790-802.
38. Shughrue, P. J.; Lane, M. V.; Merchenthaler, I. Comparative distribution of estrogen receptor-α and -β mRNA in the rat central nervous system. J. Comp. Neurol. 1997, 388(4), 507-525.
39. Mitra, S. W.; Hoskin, E.; Yudkovitz, J.; Pear, L.; Wilkinson, H. A.; Hayashi, S.; Pfaff, D. W.; Ogawa, S.; Rohrer, S. P.; Schaeffer, J. M.; McEwen, B. S.; Alves, S. E. Immunolocalization of estrogen receptor beta in the mouse brain: comparison with estrogen receptor alpha. Endocrinology 2003, 144(5), 2055-2067.
40. Herrick, S. P.; Waters, E. M.; Drake, C. T.; McEwen, B. S.; Milner, T. A. Extranuclear estrogen receptor beta immunoreactivity is on doublecortin-containing cells in the adult and neonatal rat dentate gyrus. Brain Res. 2006, 1121(1), 46-58.
41. Sierra, A.; Gottfried-Blackmore, A.; Milner, T. A.; McEwen, B. S.; Bulloch, K. Steroid hormone receptor expression and function in microglia. Glia 2008, 56(6), 659-674.
42. Adams, M. M.; Fink, S. E.; Shah, R. A.; Janssen, W. G.; Hayashi, S.; Milner, T. A.; McEwen, B. S.; Morrison, J. H. Estrogen and aging affect the subcellular distribution of estrogen receptor-alpha in the hippocampus of female rats. J. Neurosci. 2002, 22(9), 3608-3614.
43. Tsai, M. J.; O'Malley, B. W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 1994, 63, 451-486.
44. Kraichely, D. M.; Sun, J.; Katzenellenbogen, J. A.; Katzenellen-bogen, B. S. Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor- beta: correlations with biological character and distinct differences among SRC coactivator family members. Endocrinology 2000, 141(10), 3534-3545.
45. Fleming, F. J.; Hill, A. D.; McDermott, E. W.; O'Higgins, N. J.; Young, L. S. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer. J. Clin. Endocrinol. Metab. 2004, 89(1), 375-383.
46. Paech, K.; Webb, P.; Kuiper, G. G.; Nilsson, S.; Gustafsson, J.; Kushner, P. J.; Scanlan, T. S. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 1997, 277(5331), 1508-1510.
47. Saville, B.; Wormke, M.; Wang, F.; Nguyen, T.; Enmark, E.; Kuiper, G.; Gustafsson, J. A.; Safe, S. Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements. J. Biol. Chem. 2000, 275(8), 5379-5387.
48. Liu, M. M.; Albanese, C.; Anderson, C. M.; Hilty, K.; Webb, P.; Uht, R. M.; Price, R. H., Jr.; Pestell, R. G.; Kushner, P. J. Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression. J. Biol. Chem. 2002, 277(27), 24353-24360.
49. Lindberg, M. K.; Moverare, S.; Skrtic, S.; Gao, H.; Dahlman-Wright, K.; Gustafsson, J. A.; Ohlsson, C. Estrogen receptor (ER)- beta reduces ERalpha-regulated gene transcription, supporting a ying yang relationship between ERalpha and ERbeta in mice. Mol. Endocrinol. 2003, 17(2), 203-208.
50. Kelly, M. J.; Levin, E. R. Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol. Metab. 2001, 12(4), 152-156.
51. Abraham, I. M.; Todman, M. G.; Korach, K. S.; Herbison, A. E. Critical in vivo roles for classical estrogen receptors in rapid estrogen actions on intracellular signaling in mouse brain. Endocrinology 2004, 145(7), 3055-3061.
52. Samuels, I. S.; Saitta, S. C.; Landreth, G. E. MAP'ing CNS development and cognition: an ERKsome process. Neuron 2009, 61(2), 160-167.
53. Spencer, J. L.; Waters, E. M.; Romeo, R. D.; Wood, G. E.; Milner, T. A.; McEwen, B. S. Uncovering the mechanisms of estrogen effects on hippocampal function. Front Neuroendocrinol. 2008, 29(2), 219-237.
54. Kuroki, Y.; Fukushima, K.; Kanda, Y.; Mizuno, K.; Watanabe, Y. Putative membrane-bound estrogen receptors possibly stimulate mitogen-activated protein kinase in the rat hippocampus. Eur. J. Pharmacol. 2000, 400(2-3), 205-209.
55. Bryant, D. N.; Bosch, M. A.; Ronnekleiv, O. K.; Dorsa, D. M. 17- Beta estradiol rapidly enhances extracellular signal-regulated kinase 2 phosphorylation in the rat brain. Neuroscience 2005, 133(1), 343-352.
56. Singh, M. Ovarian hormones elicit phosphorylation of Akt and extracellular-signal regulated kinase in explants of the cerebral cortex. Endocrine 2001, 14(3), 407-415.
57. Cardona-Gomez, G. P.; Mendez, P.; DonCarlos, L. L.; Azcoitia, I.; Garcia-Segura, L. M. Interactions of estrogen and insulin-like growth factor-I in the brain: molecular mechanisms and functional implications. J. Steroid Biochem. Mol. Biol. 2002, 83(1-5), 211-217.
58. Toran-Allerand, C. D. Estrogen and the brain: beyond ER-alpha, ER-beta, and 17beta-estradiol. Ann. N.Y. Acad. Sci. 2005, 1052, 136-144.
59. Wu, T. W.; Wang, J. M.; Chen, S.; Brinton, R. D. 17[beta]- estradiol induced Ca2+ influx via L-type calcium channels activates the Src/ERK/cyclic-AMP response element binding protein signal pathway and BCL-2 expression in rat hippocampal neurons: A potential initiation mechanism for estrogen-induced neuroprotection. Neuroscience 2005, 135(1), 59-72.
60. Mannella, P.; Brinton, R. D. Estrogen receptor protein interaction with phosphatidylinositol 3-kinase leads to activation of phosphorylated akt and extracellular signal-regulated kinase 1/2 in the same population of cortical neurons: a unified mechanism of estrogen action. J. Neurosci. 2006, 26(37), 9439-9447.
61. Zhou, Y.; Watters, J. J.; Dorsa, D. M. Estrogen rapidly induces the phosphorylation of the cAMP response element binding protein in rat brain. Endocrinology 1996, 137(5), 2163-2166.
62. Carlstrom, L.; Ke, Z. J.; Unnerstall, J. R.; Cohen, R. S.; Pandey, S. C. Estrogen modulation of the cyclic AMP response element- binding protein pathway. Effects of long-term and acute treatments. Neuroendocrinology 2001, 74(4), 227-243.
63. Malyala, A.; Kelly, M. J.; Ronnekleiv, O. K. Estrogen modulation of hypothalamic neurons: activation of multiple signaling pathways and gene expression changes. Steroids 2005, 70(5-7), 397-406.
64. Szego, E. M.; Barabas, K.; Balog, J.; Szilagyi, N.; Korach, K. S.; Juhasz, G.; Abraham, I. M. Estrogen induces estrogen receptor alpha-dependent cAMP response element-binding protein phosphorylation via mitogen activated protein kinase pathway in basal forebrain cholinergic neurons in vivo. J. Neurosci. 2006, 26(15), 4104-4110.
65. Liu, F.; Day, M.; Muniz, L. C.; Bitran, D.; Arias, R.; Revilla-Sanchez, R.; Grauer, S.; Zhang, G.; Kelley, C.; Pulito, V.; Sung, A.; Mervis, R. F.; Navarra, R.; Hirst, W. D.; Reinhart, P. H.; Marquis, K. L.; Moss, S. J.; Pangalos, M. N.; Brandon, N. J. Activation of estrogen receptor-[beta] regulates hippocampal synaptic plasticity and improves memory. Nat. Neurosci. 2008, 11(3), 334-343.
66. Giretti, M. S.; Fu, X. D.; De Rosa, G.; Sarotto, I.; Baldacci, C.; Garibaldi, S.; Mannella, P.; Biglia, N.; Sismondi, P.; Genazzani, A. R.; Simoncini, T. Extra-nuclear signalling of estrogen receptor to breast cancer cytoskeletal remodelling, migration and invasion. PLoS ONE 2008, 3(5), e2238.
67. Okano, I.; Hiraoka, J.; Otera, H.; Nunoue, K.; Ohashi, K.; Iwashita, S.; Hirai, M.; Mizuno, K. Identification and characterization of a novel family of serine/threonine kinases containing two N-terminal LIM motifs. J. Biol. Chem. 1995, 270(52), 31321-31330.
68. Woolley, C. S.; McEwen, B. S. Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J. Neurosci. 1992, 12(7), 2549-2554.
69. Brake, W. G.; Alves, S. E.; Dunlop, J. C.; Lee, S. J.; Bulloch, K.; Allen, P. B.; Greengard, P.; McEwen, B. S. Novel target sites for estrogen action in the dorsal hippocampus: an examination of synaptic proteins. Endocrinology 2001, 142(3), 1284-1289.
70. Li, C.; Brake, W. G.; Romeo, R. D.; Dunlop, J. C.; Gordon, M.; Buzescu, R.; Magarinos, A. M.; Allen, P. B.; Greengard, P.; Luine, V.; McEwen, B. S. Estrogen alters hippocampal dendritic spine shape and enhances synaptic protein immunoreactivity and spatial memory in female mice. Proc. Natl. Acad. Sci. USA 2004, 101(7), 2185-2190.
71. Hao, J.; Janssen, W. G.; Tang, Y.; Roberts, J. A.; McKay, H.; Lasley, B.; Allen, P. B.; Greengard, P.; Rapp, P. R.; Kordower, J. H.; Hof, P. R.; Morrison, J. H. Estrogen increases the number of spinophilin-immunoreactive spines in the hippocampus of young and aged female rhesus monkeys. J. Comp. Neurol. 2003, 465(4), 540-550.
72. Tang, Y.; Janssen, W. G.; Hao, J.; Roberts, J. A.; McKay, H.; Lasley, B.; Allen, P. B.; Greengard, P.; Rapp, P. R.; Kordower, J. H.; Hof, P. R.; Morrison, J. H. Estrogen replacement increases spinophilin-immunoreactive spine number in the prefrontal cortex of female rhesus monkeys. Cereb. Cortex. 2004, 14(2), 215-223.
73. Weiland, N. G. Estradiol selectively regulates agonist binding sites on the N-methyl-D-aspartate receptor complex in the CA1 region of the hippocampus. Endocrinology 1992, 131(2), 662-668.
74. Warren, S. G.; Humphreys, A. G.; Juraska, J. M.; Greenough, W. T. LTP varies across the estrous cycle: enhanced synaptic plasticity in proestrus rats. Brain Res. 1995, 703(1-2), 26-30.
75. Gazzaley, A. H.; Weiland, N. G.; McEwen, B. S.; Morrison, J. H. Differential regulation of NMDAR1 mRNA and protein by estradiol in the rat hippocampus. J. Neurosci. 1996, 16(21), 6830-6838.
76. Cordoba Montoya, D. A.; Carrer, H. F. Estrogen facilitates induction of long term potentiation in the hippocampus of awake rats. Brain Res. 1997, 778(2), 430-438.
77. Woolley, C. S.; Weiland, N. G.; McEwen, B. S.; Schwartzkroin, P. A. Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: correlation with dendritic spine density. J. Neurosci. 1997, 17(5), 1848-1859.
78. Good, M.; Day, M.; Muir, J. L. Cyclical changes in endogenous levels of oestrogen modulate the induction of LTD and LTP in the hippocampal CA1 region. Eur. J. Neurosci. 1999, 11(12), 4476-4480.
79. Cyr, M.; Thibault, C.; Morissette, M.; Landry, M.; Di Paolo, T. Estrogen-like activity of tamoxifen and raloxifene on NMDA receptor binding and expression of its subunits in rat brain. Neuropsychopharmacology 2001, 25(2), 242-257.
80. Rudick, C. N.; Woolley, C. S. Estrogen regulates functional inhibition of hippocampal CA1 pyramidal cells in the adult female rat. J. Neurosci. 2001, 21(17), 6532-6543.
81. Adams, M. M.; Fink, S. E.; Janssen, W. G.; Shah, R. A.; Morrison, J. H. Estrogen modulates synaptic N-methyl-D-aspartate receptor subunit distribution in the aged hippocampus. J. Comp. Neurol. 2004, 474(3), 419-426.
82. Le Saux, M.; Estrada-Camarena, E.; Di Paolo, T. Selective estrogen receptor-alpha but not -beta agonist treatment modulates brain alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. J. Neurosci. Res. 2006, 84(5), 1076-1084.
83. Harris, K. M.; Stevens, J. K. Dendritic spines of CA 1 pyramidal cells in the rat hippocampus: serial electron microscopy with reference to their biophysical characteristics. J. Neurosci. 1989, 9(8), 2982-2997.
84. Neigh, G. N.; Glasper, E. R.; Kofler, J.; Traystman, R. J.; Mervis, R. F.; Bachstetter, A.; DeVries, A. C. Cardiac arrest with cardiopulmonary resuscitation reduces dendritic spine density in CA1 pyramidal cells and selectively alters acquisition of spatial memory. Eur. J. Neurosci. 2004, 20(7), 1865-1872.
85. Kopec, C. D.; Real, E.; Kessels, H. W.; Malinow, R. GluR1 links structural and functional plasticity at excitatory synapses. J. Neurosci. 2007, 27(50), 13706-13718.
86. Gould, E.; Woolley, C. S.; Frankfurt, M.; McEwen, B. S. Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J. Neurosci. 1990, 10(4), 1286-1291.
87. Leranth, C.; Shanabrough, M.; Redmond, D. E., Jr. Gonadal hormones are responsible for maintaining the integrity of spine synapses in the CA1 hippocampal subfield of female nonhuman primates. J. Comp. Neurol. 2002, 447(1), 34-42.
88. Hao, J.; Rapp, P. R.; Leffler, A. E.; Leffler, S. R.; Janssen, W. G.; Lou, W.; McKay, H.; Roberts, J. A.; Wearne, S. L.; Hof, P. R.; Morrison, J. H. Estrogen alters spine number and morphology in prefrontal cortex of aged female rhesus monkeys. J. Neurosci. 2006, 26(9), 2571-2578.
89. Mukai, H.; Tsurugizawa, T.; Murakami, G.; Kominami, S.; Ishii, H.; Ogiue-Ikeda, M.; Takata, N.; Tanabe, N.; Furukawa, A.; Hojo, Y.; Ooishi, Y.; Morrison, J. H.; Janssen, W. G.; Rose, J. A.; Cham-bon, P.; Kato, S.; Izumi, S.; Yamazaki, T.; Kimoto, T.; Kawato, S. Rapid modulation of long-term depression and spinogenesis via synaptic estrogen receptors in hippocampal principal neurons. J. Neurochem. 2007, 100(4), 950-967.
90. Bliss, T. V.; Lomo, T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J. Physiol. 1973, 232(2), 331-356.
91. Citri, A.; Malenka, R. C. Synaptic plasticity: multiple forms, functions, and mechanisms. Neuropsychopharmacology 2008, 33(1), 18-41.
92. Smith, C. C.; McMahon, L. L. Estrogen-induced increase in the magnitude of long-term potentiation occurs only when the ratio of NMDA transmission to AMPA transmission is increased. J. Neuro sci. 2005, 25(34), 7780-7791.
93. Wong, M.; Moss, R. L. Long-term and short-term electrophysiological effects of estrogen on the synaptic properties of hippocampal CA1 neurons. J. Neurosci. 1992, 12(8), 3217-3225.
94. Foy, M. R.; Xu, J.; Xie, X.; Brinton, R. D.; Thompson, R. F.; Berger, T. W. 17beta-estradiol enhances NMDA receptor-mediated EPSPs and long-term potentiation. J. Neurophysiol. 1999, 81(2), 925-929.
95. Day, M.; Sung, A.; Logue, S.; Bowlby, M.; Arias, R. Beta estrogen receptor knockout (BERKO) mice present attenuated hippocampal CA1 long-term potentiation and related memory deficits in contextual fear conditioning. Behav. Brain Res. 2005, 164(1), 128-131.
96. Dai, X.; Chen, L.; Sokabe, M. Neurosteroid estradiol rescues ischemia-induced deficit in the long-term potentiation of rat hippocampal CA1 neurons. Neuropharmacology 2007, 52(4), 1124-1138.
97. Murphy, D. D.; Cole, N. B.; Greenberger, V.; Segal, M. Estradiol increases dendritic spine density by reducing GABA neurotransmission in hippocampal neurons. J. Neurosci. 1998, 18(7), 2550-2559.
98. Luine, V. N. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp. Neurol. 1985, 89(2), 484-490.
99. Gibbs, R. B. Effects of gonadal hormone replacement on measures of basal forebrain cholinergic function. Neuroscience 2000, 101(4), 931-938.
100. Gibbs, R. B. Effects of estrogen on basal forebrain cholinergic neurons vary as a function of dose and duration of treatment. Brain Res. 1997, 757(1), 10-6.
101. Daniel, J. M.; Dohanich, G. P. Acetylcholine mediates the estrogen-induced increase in NMDA receptor binding in CA1 of the hippocampus and the associated improvement in working memory. J. Neurosci. 2001, 21(17), 6949-6956.
102. Tanapat, P.; Hastings, N. B.; Reeves, A. J.; Gould, E. Estrogen Stimulates a Transient Increase in the Number of New Neurons in the Dentate Gyrus of the Adult Female Rat. J. Neurosci. 1999, 19(14), 5792-5801.
103. Mazzucco, C. A.; Lieblich, S. E.; Bingham, B. I.; Williamson, M. A.; Viau, V.; Galea, L. A. M. Both estrogen receptor [alpha] and estrogen receptor [beta] agonists enhance cell proliferation in the dentate gyrus of adult female rats. Neuroscience 2006, 141(4), 1793-1800.
104. Perez-Martin, M.; Azcoitia, I.; Trejo, J. L.; Sierra, A.; Garcia-Segura, L. M. An antagonist of estrogen receptors blocks the induction of adult neurogenesis by insulin-like growth factor-I in the dentate gyrus of adult female rat. Eur. J. Neurosci. 2003, 18(4), 923-930.
105. Lagace, D. C.; Fischer, S. J.; Eisch, A. J. Gender and endogenous levels of estradiol do not influence adult hippocampal neurogenesis in mice. Hippocampus 2007, 17(3), 175-180.
106. Spritzer, M. D.; Galea, L. A. M. Testosterone and dihydrotestoster-one, but not estradiol, enhance survival of new hippocampal neurons in adult male rats. Dev. Neurobiol. 2007, 67(10), 1321-1333.
107. Sohrabji, F.; Lewis, D. K. Estrogen-BDNF interactions: Implications for neurodegenerative diseases. Front. Neuroendocrinol. 2006, 27(4), 404-414.
108. Scharfman, H. E.; Mercurio, T. C.; Goodman, J. H.; Wilson, M. A.; MacLusky, N. J. Hippocampal Excitability Increases during the Estrous Cycle in the Rat: A Potential Role for Brain-Derived Neurotrophic Factor. J. Neurosci. 2003, 23(37), 11641-11652.
109. Hardy, J.; Selkoe, D. J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297(5580), 353-356.
110. Paganini-Hill, A.; Henderson, V. W. Estrogen deficiency and risk of Alzheimer's disease in women. Am. J. Epidemiol. 1994, 140(3), 256-261.
111. Paganini-Hill, A.; Henderson, V. W. Estrogen replacement therapy and risk of Alzheimer disease. Arch. Intern. Med. 1996, 156(19), 2213-2217.
112. Kawas, C.; Resnick, S.; Morrison, A.; Brookmeyer, R.; Corrada, M.; Zonderman, A.; Bacal, C.; Lingle, D. D.; Metter, E. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 1997, 48(6), 1517-1521.
113. Yue, X.; Lu, M.; Lancaster, T.; Cao, P.; Honda, S.; Staufenbiel, M.; Harada, N.; Zhong, Z.; Shen, Y.; Li, R. Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model. Proc. Natl. Acad. Sci. USA 2005, 102(52), 19198-19203.
114. Iivonen, S.; Corder, E.; Lehtovirta, M.; Helisalmi, S.; Mannermaa, A.; Vepsalainen, S.; Hanninen, T.; Soininen, H.; Hiltunen, M. Polymorphisms in the CYP19 gene confer increased risk for Alz-heimer disease. Neurology 2004, 62(7), 1170-1176.
115. Simpson, E. R. Sources of estrogen and their importance. J. Steroid Biochem. Mol. Biol. 2003, 86(3-5), 225-230.
116. Rapp, S. R.; Espeland, M. A.; Shumaker, S. A.; Henderson, V. W.; Brunner, R. L.; Manson, J. E.; Gass, M. L.; Stefanick, M. L.; Lane, D. S.; Hays, J.; Johnson, K. C.; Coker, L. H.; Dailey, M.; Bowen, D. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the women's health initiative memory study: a randomized controlled trial. JAMA 2003, 289(20), 2663-2672.
117. Rossouw, J. E.; Anderson, G. L.; Prentice, R. L.; LaCroix, A. Z.; Kooperberg, C.; Stefanick, M. L.; Jackson, R. D.; Beresford, S. A.; Howard, B. V.; Johnson, K. C.; Kotchen, J. M.; Ockene, J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 2002, 288(3), 321-333.
118. Espeland, M. A.; Rapp, S. R.; Shumaker, S. A.; Brunner, R.; Manson, J. E.; Sherwin, B. B.; Hsia, J.; Margolis, K. L.; Hogan, P. E.; Wallace, R.; Dailey, M.; Freeman, R.; Hays, J. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004, 291(24), 2959-2968.
119. Craig, M. C.; Maki, P. M.; Murphy, D. G. The Women's Health Initiative Memory Study: findings and implications for treatment. Lancet Neurol. 2005, 4(3), 190-194.
120. Resnick, S. M.; Maki, P. M.; Rapp, S. R.; Espeland, M. A.; Brunner, R.; Coker, L. H.; Granek, I. A.; Hogan, P.; Ockene, J. K.; Shumaker, S. A. Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J. Clin. Endocrinol. Metab. 2006, 91(5), 1802-1810.
121. Ishunina, T. A.; Swaab, D. F. Estrogen receptor-alpha splice variants in the human brain. Gynecol. Endocrinol. 2008, 24(2), 93-98.
122. Pirskanen, M.; Hiltunen, M.; Mannermaa, A.; Helisalmi, S.; Lehtovirta, M.; Hanninen, T.; Soininen, H. Estrogen receptor beta gene variants are associated with increased risk of Alzheimer's disease in women. Eur. J. Hum. Genet. 2005, 13(9), 1000-1006.
123. Lambert, J. C.; Harris, J. M.; Mann, D.; Lemmon, H.; Coates, J.; Cumming, A.; St-Clair, D.; Lendon, C. Are the estrogen receptors involved in Alzheimer's disease? Neurosci. Lett. 2001, 306(3), 193-197.
124. Mattson, M. P. Pathways towards and away from Alzheimer's disease. Nature 2004, 430(7000), 631-639.
125. Jaffe, A. B.; Toran-Allerand, C. D.; Greengard, P.; Gandy, S. E. Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein. J. Biol. Chem. 1994, 269(18), 13065-13068.
126. Xu, H.; Gouras, G. K.; Greenfield, J. P.; Vincent, B.; Naslund, J.; Mazzarelli, L.; Fried, G.; Jovanovic, J. N.; Seeger, M.; Relkin, N. R.; Liao, F.; Checler, F.; Buxbaum, J. D.; Chait, B. T.; Thinakaran, G.; Sisodia, S. S.; Wang, R.; Greengard, P.; Gandy, S. Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat. Med. 1998, 4(4), 447-451.
127. Li, R.; Shen, Y.; Yang, L. B.; Lue, L. F.; Finch, C.; Rogers, J. Estrogen enhances uptake of amyloid beta-protein by microglia derived from the human cortex. J. Neurochem. 2000, 75(4), 1447-1454.
128. Chao, H. M.; Spencer, R. L.; Frankfurt, M.; McEwen, B. S. The effects of aging and hormonal manipulation on amyloid precursor protein APP695 mRNA expression in the rat hippocampus. J. Neuroendocrinol. 1994, 6(5), 517-521.
129. Hsiao, K.; Chapman, P.; Nilsen, S.; Eckman, C.; Harigaya, Y.; Younkin, S.; Yang, F.; Cole, G. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 1996, 274(5284), 99-102.
130. Zheng, H.; Xu, H.; Uljon, S. N.; Gross, R.; Hardy, K.; Gaynor, J.; Lafrancois, J.; Simpkins, J.; Refolo, L. M.; Petanceska, S.; Wang, R.; Duff, K. Modulation of A(beta) peptides by estrogen in mouse models. J. Neurochem. 2002, 80(1), 191-196.
131. Oddo, S.; Caccamo, A.; Shepherd, J. D.; Murphy, M. P.; Golde, T. E.; Kayed, R.; Metherate, R.; Mattson, M. P.; Akbari, Y.; LaFerla, F. M. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003, 39(3), 409-421.
132. Carroll, J. C.; Rosario, E. R.; Chang, L.; Stanczyk, F. Z.; Oddo, S.; LaFerla, F. M.; Pike, C. J. Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J. Neurosci. 2007, 27(48), 13357-13365.
133. Carroll, J. C.; Pike, C. J. Selective estrogen receptor modulators differentially regulate Alzheimer-like changes in female 3xTg-AD mice. Endocrinology 2008, 149(5), 2607-2611.
134. Behl, C.; Widmann, M.; Trapp, T.; Holsboer, F. 17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem. Biophys. Res. Commun. 1995, 216(2), 473-482.
135. Goodman, Y.; Bruce, A. J.; Cheng, B.; Mattson, M. P. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J. Neurochem. 1996, 66(5), 1836-1844.
136. Green, P. S.; Gridley, K. E.; Simpkins, J. W. Estradiol protects against beta-amyloid (25-35)-induced toxicity in SK-N-SH human neuroblastoma cells. Neurosci. Lett. 1996, 218(3), 165-168.
137. Mook-Jung, I.; Joo, I.; Sohn, S.; Kwon, H. J.; Huh, K.; Jung, M. W. Estrogen blocks neurotoxic effects of beta-amyloid (1-42) and induces neurite extension on B103 cells. Neurosci. Lett. 1997, 235(3), 101-104.
138. Pike, C. J. Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease. J. Neurochem. 1999, 72(4), 1552-1563.
139. Dubal, D. B.; Shughrue, P. J.; Wilson, M. E.; Merchenthaler, I.; Wise, P. M. Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors. J. Neurosci. 1999, 19(15), 6385-6393.
140. Nilsen, J.; Diaz Brinton, R. Mechanism of estrogen-mediated neuroprotection: regulation of mitochondrial calcium and Bcl-2 expression. Proc. Natl. Acad. Sci. USA 2003, 100(5), 2842-2847.
141. Patrone, C.; Andersson, S.; Korhonen, L.; Lindholm, D. Estrogen receptor-dependent regulation of sensory neuron survival in developing dorsal root ganglion. Proc. Natl. Acad. Sci. USA 1999, 96(19), 10905-10910.
142. Koski, C. L.; Hila, S.; Hoffman, G. E. Regulation of cytokine- induced neuron death by ovarian hormones: involvement of antiapoptotic protein expression and c-JUN N-terminal kinasemediated proapoptotic signaling. Endocrinology 2004, 145(1), 95-103.
143. Quintanilla, R. A.; Munoz, F. J.; Metcalfe, M. J.; Hitschfeld, M.; Olivares, G.; Godoy, J. A.; Inestrosa, N. C. Trolox and 17betaestradiol protect against amyloid beta-peptide neurotoxicity by a mechanism that involves modulation of the Wnt signaling pathway. J. Biol. Chem. 2005, 280(12), 11615-11625.
144. Selkoe, D. J. Alzheimer's disease is a synaptic failure. Science 2002, 298(5594), 789-791.
145. Shankar, G. M.; Li, S.; Mehta, T. H.; Garcia-Munoz, A.; Shepardson, N. E.; Smith, I.; Brett, F. M.; Farrell, M. A.; Rowan, M. J.; Lemere, C. A.; Regan, C. M.; Walsh, D. M.; Sabatini, B. L.; Selkoe, D. J. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med. 2008, 14(8), 837-842.
146. Hsieh, H.; Boehm, J.; Sato, C.; Iwatsubo, T.; Tomita, T.; Sisodia, S.; Malinow, R. AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron, 2006, 52(5), 831-843.
147. Snyder, E. M.; Nong, Y.; Almeida, C. G.; Paul, S.; Moran, T.; Choi, E. Y.; Nairn, A. C.; Salter, M. W.; Lombroso, P. J.; Gouras, G. K.; Greengard, P. Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci. 2005, 8(8), 1051-1058.
148. Lacor, P. N.; Buniel, M. C.; Furlow, P. W.; Clemente, A. S.; Velasco, P. T.; Wood, M.; Viola, K. L.; Klein, W. L. Abeta oligomerinduced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J. Neurosci. 2007, 27(4), 796-807.
149. Almeida, C. G.; Tampellini, D.; Takahashi, R. H.; Greengard, P.; Lin, M. T.; Snyder, E. M.; Gouras, G. K. Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiol. Dis. 2005, 20(2), 187-198.
150. Tyszkiewicz, J. P.; Yan, Z. beta-Amyloid peptides impair PKC- dependent functions of metabotropic glutamate receptors in prefrontal cortical neurons. J. Neurophysiol. 2005, 93(6), 3102-3111.
151. Boulware, M. I.; Weick, J. P.; Becklund, B. R.; Kuo, S. P.; Groth, R. D.; Mermelstein, P. G. Estradiol activates group I and II metabotropic glutamate receptor signaling, leading to opposing influences on cAMP response element-binding protein. J. Neurosci. 2005, 25(20), 5066-5078.
152. Ferreira, A.; Lu, Q.; Orecchio, L.; Kosik, K. S. Selective phosphorylation of adult tau isoforms in mature hippocampal neurons exposed to fibrillar A beta. Mol. Cell. Neurosci. 1997, 9(3), 220-234.
153. Pei, J. J.; Braak, E.; Braak, H.; Grundke-Iqbal, I.; Iqbal, K.; Winblad, B.; Cowburn, R. F. Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes. J. Neuropathol. Exp. Neurol. 1999, 58(9), 1010-1019.
154. Goodenough, S.; Schleusner, D.; Pietrzik, C.; Skutella, T.; Behl, C. Glycogen synthase kinase 3beta links neuroprotection by 17beta- estradiol to key Alzheimer processes. Neuroscience 2005, 132(3), 581-589.
155. Shi, H. R.; Zhu, L. Q.; Wang, S. H.; Liu, X. A.; Tian, Q.; Zhang, Q.; Wang, Q.; Wang, J. Z. 17beta-estradiol attenuates glycogen synthase kinase-3beta activation and tau hyperphosphorylation in Akt-independent manner. J. Neural. Transm. 2008, 115(6), 879-888.
156. Corder, E. H.; Saunders, A. M.; Strittmatter, W. J.; Schmechel, D. E.; Gaskell, P. C.; Small, G. W.; Roses, A. D.; Haines, J. L.; Pericak-Vance, M. A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993, 261(5123), 921-923.
157. Yaffe, K.; Haan, M.; Byers, A.; Tangen, C.; Kuller, L. Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction. Neurology, 2000, 54(10), 1949-1954.
158. Jiang, Q.; Lee, C. Y.; Mandrekar, S.; Wilkinson, B.; Cramer, P.; Zelcer, N.; Mann, K.; Lamb, B.; Willson, T. M.; Collins, J. L.; Richardson, J. C.; Smith, J. D.; Comery, T. A.; Riddell, D.; Holtzman, D. M.; Tontonoz, P.; Landreth, G. E. ApoE promotes the proteolytic degradation of Abeta. Neuron, 2008, 58(5), 681-693.
159. Stone, D. J.; Rozovsky, I.; Morgan, T. E.; Anderson, C. P.; Hajian, H.; Finch, C. E. Astrocytes and microglia respond to estrogen with increased apoE mRNA in vivo and in vitro. Exp. Neurol. 1997, 143(2), 313-318.
160. Rozovsky, I.; Hoving, S.; Anderson, C. P.; O'Callaghan, J.; Finch, C. E. Equine estrogens induce apolipoprotein E and glial fibrillary acidic protein in mixed glial cultures. Neurosci. Lett. 2002, 323(3), 191-194.
161. Struble, R. G.; Rosario, E. R.; Kircher, M. L.; Ludwig, S. M.; McAdamis, P. J.; Watabe, K.; McAsey, M. E.; Cady, C.; Nathan, B. P. Regionally specific modulation of brain apolipoprotein E in the mouse during the estrous cycle and by exogenous 17beta estradiol. Exp. Neurol. 2003, 183(2), 638-644.
162. Wang, J. M.; Irwin, R. W.; Brinton, R. D. Activation of estrogen receptor alpha increases and estrogen receptor beta decreases apolipoprotein E expression in hippocampus in vitro and in vivo. Proc. Natl. Acad. Sci. USA 2006, 103(45), 16983-16988.
163. Markowska, A. L.; Savonenko, A. V. Effectiveness of estrogen replacement in restoration of cognitive function after long-term estrogen withdrawal in aging rats. J. Neurosci. 2002, 22(24), 10985-10995.
164. Rapp, P. R.; Morrison, J. H.; Roberts, J. A. Cyclic estrogen replacement improves cognitive function in aged ovariectomized rhesus monkeys. J. Neurosci. 2003, 23(13), 5708-5714.
165. Hao, J.; Rapp, P. R.; Janssen, W. G.; Lou, W.; Lasley, B. L.; Hof, P. R.; Morrison, J. H. Interactive effects of age and estrogen on cognition and pyramidal neurons in monkey prefrontal cortex. Proc. Natl. Acad. Sci. USA 2007, 104(27), 11465-11470.
166. Narita, M.; Kuzumaki, N.; Miyatake, M.; Sato, F.; Wachi, H.; Seyama, Y.; Suzuki, T. Role of delta-opioid receptor function in neurogenesis and neuroprotection. J. Neurochem. 2006, 97(5), 1494-1505.
167. Sandstrom, N. J.; Williams, C. L. Memory retention is modulated by acute estradiol and progesterone replacement. Behav. Neurosci. 2001, 115(2), 384-393.
168. Sandstrom, N. J.; Williams, C. L. Spatial memory retention is enhanced by acute and continuous estradiol replacement. Horm. Behav. 2004, 45(2), 128-135.
169. Freedman, R. Schizophrenia. N. Engl. J. Med. 2003, 349(18), 1738-1749.
170. Weinberger, D. R. From neuropathology to neurodevelopment. Lancet, 1995, 346(8974), 552-557.
171. Jarskog, L. F.; Miyamoto, S.; Lieberman, J. A. Schizophrenia: new pathological insights and therapies. Annu. Rev. Med. 2007, 58, 49-61.
172. Tsuang, M. Schizophrenia: genes and environment. Biol. Psychiatry 2000, 47(3), 210-20.
173. Canuso, C. M.; Pandina, G. Gender and schizophrenia. Psychopharmacol. Bull. 2007, 40(4), 178-190.
174. Hafner, H. Gender differences in schizophrenia. Psychoneuroendo crinology 2003, 28(Suppl. 2), 17-54.
175. Seeman, M. V.; Lang, M. The role of estrogens in schizophrenia gender differences. Schizophr. Bull. 1990, 16(2), 185-194.
176. Hafner, H.; Riecher-Rossler, A.; An Der Heiden, W.; Maurer, K.; Fatkenheuer, B.; Loffler, W. Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia. Psychol. Med. 1993, 23(4), 925-940.
177. Salokangas, R. K. Gender and the use of neuroleptics in schizophrenia. Further testing of the oestrogen hypothesis. Schizophr. Res. 1995, 16(1), 7-16.
178. Salokangas, R. K. Gender and the use of neuroleptics in schizophrenia. Schizophr. Res. 2004, 66(1), 41-49.
179. Bergemann, N.; Mundt, C.; Parzer, P.; Jannakos, I.; Nagl, I.; Salbach, B.; Klinga, K.; Runnebaum, B.; Resch, F. Plasma concentrations of estradiol in women suffering from schizophrenia treated with conventional versus atypical antipsychotics. Schizophr. Res. 2005, 73(2-3), 357-366.
180. Bergemann, N.; Parzer, P.; Nagl, I.; Salbach, B.; Runnebaum, B.; Mundt, C.; Resch, F. Acute psychiatric admission and menstrual cycle phase in women with schizophrenia. Arch. Womens Ment. Health 2002, 5(3), 119-126.
181. Hirano, S.; Miyata, S.; Onodera, K.; Kamei, J. Effects of histamine H1 receptor antagonists on depressive-like behavior in diabetic mice. Pharmacol. Biochem. Behavior. 2006, 83(2), 214-220.
182. Kulkarni, J.; de Castella, A.; Smith, D.; Taffe, J.; Keks, N.; Copolov, D. A clinical trial of the effects of estrogen in acutely psychotic women. Schizophr. Res. 1996, 20(3), 247-252.
183. Kulkarni, J.; Riedel, A.; de Castella, A. R.; Fitzgerald, P. B.; Rolfe, T. J.; Taffe, J.; Burger, H. Estrogen a potential treatment for schizophrenia. Schizophr. Res. 2001, 48(1), 137-144.
184. Kulkarni, J.; de Castella, A.; Fitzgerald, P. B.; Gurvich, C. T.; Bailey, M.; Bartholomeusz, C.; Burger, H. Estrogen in severe mental illness: a potential new treatment approach. Arch. Gen. Psychiatry. 2008, 65(8), 955-960.
185. Lindamer, L. A.; Buse, D. C.; Lohr, J. B.; Jeste, D. V. Hormone replacement therapy in postmenopausal women with schizophrenia: positive effect on negative symptoms? Biol. Psychiatry. 2001, 49(1), 47-51.
186. Perlman, W. R.; Tomaskovic-Crook, E.; Montague, D. M.; Webster, M. J.; Rubinow, D. R.; Kleinman, J. E.; Weickert, C. S. Alteration in estrogen receptor alpha mRNA levels in frontal cortex and hippocampus of patients with major mental illness. Biol. Psychiatry. 2005, 58(10), 812-824.
187. Weickert, C. S.; Miranda-Angulo, A. L.; Wong, J.; Perlman, W. R.; Ward, S. E.; Radhakrishna, V.; Straub, R. E.; Weinberger, D. R.; Kleinman, J. E. Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia. Hum. Mol. Genet. 2008, 17(15),2293-2309.
188. Castner, S. A.; Xiao, L.; Becker, J. B. Sex differences in striatal dopamine: in vivo microdialysis and behavioral studies. Brain Res. 1993, 610(1), 127-134.
189. Le Saux, M.; Morissette, M.; Di Paolo, T. ERbeta mediates the estradiol increase of D2 receptors in rat striatum and nucleus accumbens. Neuropharmacology. 2006, 50(4), 451-457.
190. Le Saux, M.; Di Paolo, T. Influence of oestrogenic compounds on monoamine transporters in rat striatum. J. Neuroendocrinol. 2006, 18(1), 25-32.
191. Di Paolo, T.; Poyet, P.; Labrie, F. Effect of chronic estradiol and haloperidol treatment on striatal dopamine receptors. Eur. J. Pharmacol. 1981, 73(1), 105-106.
192. Ferretti, C.; Ghi, P.; Blengio, M.; Gaietta, G.; Barrera, G.; Genazzani, E. Are the catecholestrogens involved in estrogen-induced striatal dopamine receptor supersensitivity? Eur. J. Pharmacol. 1989, 166(2), 149-156.
193. Morissette, M.; Le Saux, M.; D'Astous, M.; Jourdain, S.; Al Sweidi, S.; Morin, N.; Estrada-Camarena, E.; Mendez, P.; Garcia-Segura, L. M.; Di Paolo, T. Contribution of estrogen receptors alpha and beta to the effects of estradiol in the brain. J. Steroid Biochem. Mol. Biol. 2008, 108(3-5), 327-338.
194. Becker, J. B.; Rudick, C. N. Rapid effects of estrogen or progester-one on the amphetamine-induced increase in striatal dopamine are enhanced by estrogen priming: a microdialysis study. Pharmacol. Biochem. Behav. 1999, 64(1), 53-57.
195. Hughes, Z. A.; Liu, F.; Platt, B. J.; Dwyer, J. M.; Pulicicchio, C. M.; Zhang, G.; Schechter, L. E.; Rosenzweig-Lipson, S.; Day, M. WAY-200070, a selective agonist of estrogen receptor beta as a potential novel anxiolytic/antidepressant agent. Neuropharmacol. 2008, 54(7), 1136-1142.
196. Kuppers, E.; Beyer, C. Expression of estrogen receptor-alpha and beta mRNA in the developing and adult mouse striatum. Neurosci. Lett. 1999, 276(2), 95-98.
197. Creutz, L. M.; Kritzer, M. F. Estrogen receptor-beta immunoreactivity in the midbrain of adult rats: regional, subregional, and cellular localization in the A10, A9, and A8 dopamine cell groups. J. Comp. Neurol. 2002, 446(3), 288-300.
198. Javitt, D. C. Glutamate and schizophrenia: phencyclidine, N- methyl-d-aspartate receptors, and dopamine-glutamate interactions. Int. Rev. Neurobiol. 2007, 78, 69-108.
199. Woolley, C. S. Estrogen-mediated structural and functional synaptic plasticity in the female rat hippocampus. Horm. Behav. 1998, 34(2), 140-148.
200. Bertrand, P. P.; Paranavitane, U. T.; Chavez, C.; Gogos, A.; Jones, M.; van den Buuse, M. The effect of low estrogen state on serotonin transporter function in mouse hippocampus: a behavioral and electrochemical study. Brain Res. 2005, 1064(1-2), 10-20.
201. Glantz, L. A.; Lewis, D. A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiatry, 2000, 57(1), 65-73.
202. Honea, R.; Crow, T. J.; Passingham, D.; Mackay, C. E. Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel- based morphometry studies. Am. J. Psychiatry, 2005, 162(12), 2233-2245.
203. Jelks, K. B.; Wylie, R.; Floyd, C. L.; McAllister, A. K.; Wise, P. Estradiol targets synaptic proteins to induce glutamatergic synapse formation in cultured hippocampal neurons: critical role of estrogen receptor-alpha. J. Neurosci. 2007, 27(26), 6903-6913.
204. Kessler, R. C. Epidemiology of women and depression. J. Affec. Disord. 2003, 74(1), 5-13.
205. Weissman, M. M.; Bland, R.; Joyce, P. R.; Newman, S.; Wells, J. E.; Wittchen, H.-U. Sex differences in rates of depression: cross-national perspectives. J. Affec. Disord. 1993, 29(2-3), 77-84.
206. Payne, J. L. The role of estrogen in mood disorders in women. Int. Rev. Psychiatry 2003, 15(3), 280-290.
207. Martenyi, F.; Dossenbach, M.; Mraz, K.; Metcalfe, S. Gender differences in the efficacy of fluoxetine and maprotiline in depressed patients: a double-blind trial of antidepressants with serotonergic or norepinephrinergic reuptake inhibition profile. Eur. Neuropsychopharmaco. 2001, 11(3), 227-232.
208. Stewart, D. E.; Rolfe, D. E.; Robertson, E. Depression, estrogen, and the women's health initiative. Psychosomatics 2004, 45(5), 445-447.
209. Avis, N. E.; Crawford, S.; Stellato, R.; Longcope, C. Longitudinal study of hormone levels and depression among women transitioning through menopause. Climacteric 2001, 4(3), 243-249.
210. de Novaes Soares, C.; Almeida, O. P.; Joffe, H.; Cohen, L. S. Efficacy of Estradiol for the Treatment of Depressive Disorders in Perimenopausal Women: A Double-blind, Randomized, Placebo- Controlled Trial. Arch. Gen. Psychiatry 2001, 58(6), 529-534.
211. Rasgon, N. L.; Dunkin, J.; Fairbanks, L.; Altshuler, L. L.; Troung, C.; Elman, S.; Wroolie, T. E.; Brunhuber, M. V.; Rapkin, A. Estrogen and response to sertraline in postmenopausal women with major depressive disorder: A pilot study. J. Psychiatric Res. 2007, 41(3-4), 338-343.
212. Zanardi, R.; Rossini, D.; Magri, L.; Malaguti, A.; Colombo, C.; Smeraldi, E. Response to SSRIs and role of the hormonal therapy in post-menopausal depression. Eur. Neuropsychopharmaco. 2007, 17(6-7), 400-405.
213. Westlund Tam, L.; Parry, B. L. Does estrogen enhance the antide-pressant effects of fluoxetine? J. Affec. Disord. 2003, 77(1), 87-92.
214. Morgan, M. L.; Cook, I. A.; Rapkin, A. J.; Leuchter, A. F. Estrogen augmentation of antidepressants in perimenopausal depression: a pilot study. J. Clin. Psychiatry 2005, 66(6), 774-780.
215. Morrison, M. F.; Kallan, M. J.; Ten Have, T.; Katz, I.; Tweedy, K.; Battistini, M. Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial. Biological Psychiatry 2004, 55(4), 406-412.
216. Amsterdam, J.; Garcia-España, F.; Fawcett, J.; Quitkin, F.; Reimherr, F.; Rosenbaum, J.; Beasley, C. Fluoxetine efficacy in menopausal women with and without estrogen replacement. J. Affec. Disord. 1999, 55(1), 11-17.
217. Walf, A. A.; Rhodes, M. E.; Frye, C. A. Antidepressant effects of ER[beta]-selective estrogen receptor modulators in the forced swim test. Pharmacol. Biochem. Behav. 2004, 78(3), 523-529.
218. Rachman, I. M.; Unnerstall, J. R.; Pfaff, D. W.; Cohen, R. S. Estrogen alters behavior and forebrain c-fos expression in ovariectomized rats subjected to the forced swim test. PNAS 1998, 95(23), 13941-13946.
219. Tasset, I.; Pena, J.; Jimena, I.; Feijoo, M.; del Carmen Munoz, M.; Montilla, P.; Tunez, I. Effect of 17 beta-estradiol on olfactory bulbectomy-induced oxidative stress and behavioral changes in rats. Neuropsychiatr. Dis. Trea. 2008, 4(2), 441-449.
220. Rocha, B. A.; Fleischer, R.; Schaeffer, J. M.; Rohrer, S. P.; Hickey, G. J. 17b-Estradiol-induced antidepressant-like effect in the Forced Swim Test is absent in estrogen receptor-b knockout (BERKO) mice. Psychopharmacology 2005, 179(3), 637-643.
221. Weiser, M. J.; Wu, T. J.; Handa, R. J. Estrogen receptor beta agonist diarylpropionitrile (DPN): biological activities of R- and S- enantiomers on behavior and hormonal response to stress. Endocrinology 2009, 150(4), 1817-18125.
222. Marcondes, F. K.; Miguel, K. J.; Melo, L. L.; Spadari-Bratfisch, R. C. Estrous cycle influences the response of female rats in the elevated plus-maze test. Physiol. Behav. 2001, 74(4-5), 435-440.
223. Lund, T. D.; Rovis, T.; Chung, W. C. J.; Handa, R. J. Novel actions of estrogen receptor-beta on anxiety-related behaviors. Endocrinology 2005, 146(2), 797-807.
224. Walf, A. A.; Frye, C. A. ERbeta-selective estrogen receptor modulators produce antianxiety behavior when administered systemically to ovariectomized rats. Neuropsychopharmacology 2005, 30(9), 1598-1609.
225. Walf, A. A.; Koonce, C. J.; Frye, C. A. Estradiol or diarylpropionitrile decrease anxiety-like behavior of wildtype, but not estrogen receptor beta knockout, mice. Behav. Neurosci. 2008, 122(5), 974-981.
226. Imwalle, D. B.; Gustafsson, J. A.; Rissman, E. F. Lack of functional estrogen receptor beta influences anxiety behavior and serotonin content in female mice. Physiol. Behav. 2005, 84(1), 157-163.
227. Gundlah, C.; Lu, N. Z.; Mirkes, S. J.; Bethea, C. L. Estrogen receptor beta (ERb) mRNA and protein in serotonin neurons of macaques. Mol. Brain Res. 2001, 91(1-2), 14-22.
228. Gundlah, C.; Alves, S. E.; Clark, J. A.; Pai, L.-Y.; Schaeffer, J. M.; Rohrer, S. P. Estrogen receptor-[beta] regulates tryptophan hydroxylase-1 expression in the murine midbrain raphe. Biological Psychiatry, 2005, 57(8), 938-942.
229. Pecins-Thompson, M.; Bethea, C. L. Ovarian steroid regulation of 5-HT1A autoreceptor mRNA expression in the dorsal raphe of rhesus macaques. Neuroscience 1999, 89(1), 267-277.
230. Pecins-Thompson, M.; Brown, N. A.; Kohama, S. G.; Bethea, C. L. Ovarian steroid regulation of tryptophan hydroxylase mRNA expression in rhesus macaques. J. Neurosci. 1996, 16(21), 7021-7029.
231. Le Saux, M.; Di Paolo, T. Changes in 5-HT1A receptor binding and G-protein activation in the rat brain after estrogen treatment: comparison with tamoxifen and raloxifene. J. Psychiatr Neurosci. 2005, 30(2), 110-117.
232. Suzuki, S.; Handa, R. J. Estrogen receptor-β, but not estrogen receptor-α, is expressed in prolactin neurons of the female rat paraventricular and supraoptic nuclei: Comparison with other neuropeptides. J. Comp. Neurol. 2005, 484(1), 28-42.
233. Laflamme, N.; Nappi, R. E.; Drolet, G.; Labrie, C.; Rivest, S. Expression and neuropeptidergic characterization of estrogen receptors (ERalpha and ERbeta) throughout the rat brain: anatomical evidence of distinct roles of each subtype. J. Neurobiol. 1998, 36(3), 357-378.
234. Hrabovszky, E.; Kalló, I.; Steinhauser, A.; Merchenthaler, I.; Coen, C. W.; Petersen, S. L.; Liposits, Z. Estrogen receptor-beta in oxytocin and vasopressin neurons of the rat and human hypothalamus: Immunocytochemical and in situ hybridization studies. J. Comp. Neurol. 2004, 473(3), 315-333.
235. Van Den Eede, F.; Van Broeckhoven, C.; Claes, S. J. Corticotropin-releasing factor-binding protein, stress and major depression. Ageing Res. Rev. 2005, 4(2), 213-239.
236. van de Stolpe, A.; Slycke, A. J.; Reinders, M. O.; Zomer, A. W. M.; Goodenough, S.; Behl, C.; Seasholtz, A. F.; van der Saag, P. T. Estrogen receptor (ER)-mediated transcriptional regulation of the human corticotropin-releasing hormone-binding protein promoter: differential effects of ER{alpha} and ER{beta}. Mol. Endocrinol. 2004, 18(12), 2908-2923.
237. Speert, D. B.; SJ, M. C.; Seasholtz, A. F. Sexually dimorphic expression of corticotropin-releasing hormone-binding protein in the mouse pituitary. Endocrinology, 2002, 143(12), 4730-4741.
238. Schulz, D. W.; Mansbach, R. S.; Sprouse, J.; Braselton, J. P.; Collins, J.; Corman, M.; Dunaiskis, A.; Faraci, S.; Schmidt, A. W.; Seeger, T.; Seymour, P.; Tingley, F. D., 3rd; Winston, E. N.; Chen, Y. L.; Heym, J. CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. Proc. Natl. Acad. Sci. USA, 1996, 93(19), 10477-10482.
239. Owens, M. J.; Nemeroff, C. B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev. 1991, 43(4), 425-473.
240. Ochedalski, T.; Subburaju, S.; Wynn, P. C.; Aguilera, G. Interaction Between Oestrogen and Oxytocin on Hypothalamic-Pituitary-Adrenal Axis Activity. J. Neuroendocrinol. 2007, 19(3), 189-197.
241. Gleason, S. D.; Witkin, J. M. A parametric analysis of punishment frequency as a determinant of the response to chlordiazepoxide in the Vogel conflict test in rats. Pharmacol. Biochem. Behav. 2007, 87(3), 380-385.
242. McCarthy, M. M.; McDonald, C. H.; Brooks, P. J.; Goldman, D. An Anxiolytic Action of Oxytocin is Enhanced by Estrogen in the Mouse. Physiolo. Behav. 1997, 60(5), 1209-1215.
243. Hoshaw, B. A.; Evans, J. C.; Mueller, B.; Valentino, R. J.; Lucki, I. Social competition in rats: Cell proliferation and behavior. Behav. Brain Res. 2006, 175(2), 343-351.
244. Sajdyk, T. J.; Vandergriff, M. G.; Gehlert, D. R. Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test. Eur. J. Pharmacol. 1999, 368(2-3), 143-147.
245. Heilig, M. The NPY system in stress, anxiety and depression. Neuropeptides 2004, 38(4), 213-224.
246. Pioli, P. A.; Jensen, A. L.; Weaver, L. K.; Amiel, E.; Shen, Z.; Shen, L.; Wira, C. R.; Guyre, P. M. Estradiol attenuates lipopolysaccharide-induced CXC chemokine ligand 8 production by human peripheral blood monocytes. J. Immunol. 2007, 179(9), 6284-6290.
247. Garidou, L.; Laffont, S.; Douin-Echinard, V.; Coureau, C.; Krust, A.; Chambon, P.; Guery, J.-C. Estrogen Receptor {alpha} Signaling in Inflammatory Leukocytes Is Dispensable for 17{beta}- Estradiol-Mediated Inhibition of Experimental Autoimmune Encephalomyelitis. J. Immunol. 2004, 173(4), 2435-2442.
248. Lewis, D. K.; Johnson, A. B.; Stohlgren, S.; Harms, A.; Sohrabji, F. Effects of estrogen receptor agonists on regulation of the inflammatory response in astrocytes from young adult and middleaged female rats. J. Neuroimmunol. 2008, 195(1-2), 47-59.
249. Raison, C. L.; Capuron, L.; Miller, A. H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006, 27(1), 24-31.
250. Denicoff, K. D.; Rubinow, D. R.; Papa, M. Z.; Simpson, C.; Seipp, C. A.; Lotze, M. T.; Chang, A. E.; Rosenstein, D.; Rosenberg, S. A. The Neuropsychiatric Effects of Treatment with Interleukin-2 and Lymphokine-Activated Killer Cells. Ann. Intern. Med. 1987, 107(3), 293.
251. Renault, P. F.; Hoofnagle, J. H.; Park, Y.; Mullen, K. D.; Peters, M.; Jones, D. B.; Rustgi, V.; Jones, E. A. Psychiatric complications of long-term interferon alfa therapy. Arch. Intern. Med. 1987, 147(9), 1577-1580.
252. Kentner, A. C.; Miguelez, M.; James, J. S.; Bielajew, C. Behavioral and physiological effects of a single injection of rat interferon-alpha on male Sprague-Dawley rats: A long-term evaluation. Brain Res. 2006, 1095(1), 96-106.
253. Harris, H. A.; Albert, L. M.; Leathurby, Y.; Malamas, M. S.; Mewshaw, R. E.; Miller, C. P.; Kharode, Y. P.; Marzolf, J.; Komm, B. S.; Winneker, R. C.; Frail, D. E.; Henderson, R. A.; Zhu, Y.; Keith, J. C., Jr. Evaluation of an estrogen receptor-beta agonist in animal models of human disease. Endocrinology 2003, 144(10), 4241-9.
254. Harris, H. A. The unexpected science of estrogen receptor-beta selective agonists: a new class of anti-inflammatory agents? Nucl. Recept. Signal. 2006, 4, e012.
255. Elloso, M. M.; Phiel, K.; Henderson, R. A.; Harris, H. A.; Adelman, S. J. Suppression of experimental autoimmune encephalomyelitis using estrogen receptor-selective ligands. J. Endocrinol. 2005, 185(2), 243-252.
256. Tiwari-Woodruff, S.; Morales, L. B. J.; Lee, R.; Voskuhl, R. R. Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)α and ERÎ2 ligand treatment. Proc. Natl. Acad. Sci. USA 2007, 104(37), 14813-14818.
257. Ralston, S. H.; Russell, R. G.; Gowen, M. Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women. J. Bone Mineral Res. 1990, 5(9), 983-8.
258. Stein, B.; Yang, M. X. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta. Mol. Cell. Biol. 1995, 15(9), 4971-4979.
259. Ray, P.; Ghosh, S. K.; Zhang, D. -H.; Ray, A. Repression of interleukin-6 gene expression by 17[beta]-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF- [kappa]B by the estrogen receptor. FEBS Lett. 1997, 409(1), 79-85.
260. Cvoro, A.; Tatomer, D.; Tee, M. -K.; Zogovic, T.; Harris, H. A.; Leitman, D. C. Selective Estrogen Receptor-Agonists Repress Transcription of Proinflammatory Genes. J. Immunol. 2008, 180(1), 630-636.
261. Riley, J. L.; Robinson, M. E.; Wise, E. A.; Myers, C. D.; Fillingim, R. B. Sex differences in the perception of noxious experimental stimuli: a meta-analysis. Pain 1998, 74(2-3), 181-187.
262. Riley, J. L.; Robinson, M. E.; Wise, E. A.; Price, D. D. A meta-analytic review of pain perception across the menstrual cycle. Pain 1999, 81(3), 225-235.
263. Berkley, K. J. Sex differences in pain. Behav. Brain Sci. 1997, 20(3), 371-380.
264. Dietrich, W.; Haitel, A.; Holzer, G.; Huber, J. C.; Kolbus, A.; Tschugguel, W. Estrogen receptor-beta is the predominant estrogen receptor subtype in normal human synovia. J. Soc. Gynecol. Investig. 2006, 13(7), 512-517.
265. Burke, K. A.; Schroeder, D. M.; Abel, R. A.; Richardson, S. C.; Bigsby, R. M.; Nephew, K. P. Immunohistochemical detection of estrogen receptor alpha in male rat spinal cord during development. J. Neurosci. Res. 2000, 61(3), 329-337.
266. Papka, R. E.; Srinivasan, B.; Miller, K. E.; Hayashi, S. Localization of estrogen receptor protein and estrogen receptor messenger RNA in peripheral autonomic and sensory neurons. Neuroscience 1997, 79(4), 1153-1163.
267. Papka, R. E.; Storey-Workley, M. Estrogen receptor-alpha and - beta coexist in a subpopulation of sensory neurons of female rat dorsal root ganglia. Neurosci. Lett. 2002, 319(2), 71-74.
268. Bennett, H. L.; Gustafsson, J. A.; Keast, J. R. Estrogen receptor expression in lumbosacral dorsal root ganglion cells innervating the female rat urinary bladder. Auton. Neurosci. 2003, 105(2), 90-100.
269. Papka, R. E.; Storey-Workley, M.; Shughrue, P. J.; Merchenthaler, I.; Collins, J. J.; Usip, S.; Saunders, P. T. K.; Shupnik, M. Estrogen receptor-alpha and -beta immunoreactivity and mRNA in neurons of sensory and autonomic ganglia and spinal cord. Cell Tissue Res. 2001, 304(2), 193-214.
270. Fan, X. T.; Kim, H. J.; Warner, M.; Gustafsson, J. A. Estrogen receptor beta is essential for sprouting of nociceptive primary afferents and for morphogenesis and maintenance of the dorsal horn interneurons. Proc. Natl. Acad. Sci. USA, 2007, 104(34), 13696-13701.
271. Liu, X.; Fan, X. L.; Zhao, Y.; Luo, G. R.; Li, X. P.; Li, R.; Le, W. D. Estrogen provides neuroprotection against activated microglia- induced dopaminergic neuronal injury through both estrogen receptor. J. Neurosci. Res. 2005, 81(5), 653-665.
272. Follettie, M. T.; Pinard, M.; Keith, J. C.; Wang, L. L.; Chelsky, D.; Hayward, C.; Kearney, P.; Thibault, P.; Paramithiotis, E.; Dorner, A. J.; Harris, H. A. Organ messenger ribonucleic acid and plasma proteome changes in the adjuvant-induced arthritis model: Responses to disease induction and therapy with the estrogen receptor-beta selective agonist ERB-041. Endocrinology, 2006, 147(2), 714-723.
273. Harris, H. A.; Bruner-Tran, K. L.; Zhang, X. C.; Osteen, K. G.; Lyttle, C. R. A selective estrogen receptor-beta agonist causes lesion regression in an experimentally induced model of endometriosis. Human Reprod., 2005, 20, 936-941.
274. Leventhal, L.; Brandt, M. R.; Cummons, T. A.; Piesla, M. J.; Rogers, K. E.; Harris, H. A. An estrogen receptor-beta agonist is active in models of inflammatory and chemical-induced pain. Eur. J. Pharmacol. 2006, 553(1-3), 146-148.
275. Zhao, X.; Liu, J.; Guan, R.; Shen, Y.; Xu, P.; Xu, J. G. Estrogen affects BDNF expression following chronic constriction nerve injury. Neuroreport 2003, 14(12), 1627-1631.
276. Shir, Y.; Campbell, J. N.; Raja, S. N.; Seltzer, Z. The correlation between dietary soy phytoestrogens and neuropathic pain behavior in rats after partial denervation. Anesth. Analg. 2002, 94(2), 421-426.
277. Scholz, J.; Woolf, C. J. The neuropathic pain triad: Neurons, immune cells and glia. Nat. Neurosci. 2007, 10(11), 1361-1368.
278. Shehab, S. A.; Spike, R. C.; Todd, A. J. Do central terminals of intact myelinated primary afferents sprout into the superficial dorsal horn of rat spinal cord after injury to a neighboring peripheral nerve? J. Comp. Neurol. 2004, 474(3), 427-437.
279. Scholz, J.; Broom, D. C.; Youn, D. H.; Mills, C. D.; Kohno, T.; Suter, M. R.; Moore, K. A.; Decosterd, I.; Coggeshall, R. E.; Woolf, C. J. Blocking caspase activity prevents transsynaptic neuronal apoptosis and the loss of inhibition in lamina II of the dorsal horn after peripheral nerve injury. J. Neurosci. 2005, 25(32), 7317-7323.
280. Whiteside, G. T.; Munglani, R. Cell death in the superficial dorsal horn in a model of neuropathic pain. J. Neurosci. Res. 2001, 64(2), 168-173.
281. Ledeboer, A.; Sloane, E. M.; Milligan, E. D.; Frank, M. G.; Mahony, J. H.; Maier, S. F.; Watkins, L. R. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain 2005, 115(1-2), 71-83.
282. Coull, J. A. M.; Beggs, S.; Boudreau, D.; Boivin, D.; Tsuda, M.; Inoue, K.; Gravel, C.; Salter, M. W.; De Koninck, Y. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 2005, 438(7070), 1017-1021.
283. Moalem, G.; Tracey, D. J. Immune and inflammatory mechanisms in neuropathic pain. Brain Res. Rev. 2006, 51(2), 240-264.